Dermatology

>

Latest News

Nonsteroidal Topical Treatments for Eczema: A Product Snapshot with Mona Shahriari, MD / image credit Central Connecticut Dermatology
Nonsteroidal Topical Treatments for Eczema: A Product Snapshot with Mona Shahriari, MD

November 6th 2024

They are a Janus kinase (JAK)1/JAK2 inhibitor, a phosphodiesterase-4 inhibitor, and an investigational aryl hydrocarbon receptor agonist. Learn more about each.

FDA Pushes Back PDUFA Date 3 Months for Tapinarof, 1% Cream for Atopic Dermatitis in Adults and Children / image credit ©Organon
FDA Pushes Back PDUFA Date 3 Months for Tapinarof, 1% Cream for Atopic Dermatitis in Adults and Children

November 5th 2024

Atopic Dermatitis: Final ADORING 3 Open-Lael Extension Trial Findings with Tapinarof 1% Announced / image credit atopic dermatitis concept  ©New Africa/stock.adobe.com
Atopic Dermatitis: Final ADORING 3 Open-Label Extension Trial Findings with Tapinarof Cream, 1% Announced

October 31st 2024

Dupilumab Efficacy for Severe Atopic Dermatitis Durable at 5 Years: New Data
Dupilumab Efficacy for Severe Atopic Dermatitis Durable at 5 Years: New Data

October 25th 2024

Lebrikizumab Demonstrates Sustained Disease Control in Atopic Dermatitis Up to 3 Years / image credit - Lilly logo: ©Michael Vi/stock.adobe.com
Lebrikizumab Demonstrates Sustained Disease Control in Atopic Dermatitis Up to 3 Years

September 25th 2024

Latest CME Events & Activities

Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)

View More

Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia

View More

Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis

November 21, 2024 - December 5, 2024

View More

Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!

View More

21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

February 8, 2025

View More

Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis

View More

Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making

View More

Tumor-Infiltrating Lymphocyte Therapy Advances Into Melanoma

View More

Community Practice Connections™: 20th Annual International Symposium on Melanoma and Other Cutaneous Malignancies

View More

Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis

View More

Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color

View More

Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach

View More

Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis

View More

Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis

View More

More News

© 2024 MJH Life Sciences

All rights reserved.